UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

fMRI study of olfactory processing in mice under three anesthesia protocols: Insight into the effect of ketamine on olfactory processing

NeuroImage (Orlando, Fla.), 2020-06, Vol.213, p.116725-116725, Article 116725

2020

Volltextzugriff (PDF)

fMRI study of the role of glutamate NMDA receptor in the olfactory processing in monkeys

PloS one, 2018-06, Vol.13 (6), p.e0198395-e0198395

2018

Volltextzugriff (PDF)

Translational Pharmacokinetic-Pharmacodynamic Modeling of NaV1.7 Inhibitor MK-2075 to Inform Human Efficacious Dose

Frontiers in pharmacology, 2021-12, Vol.12, p.786078-786078

2021

Volltextzugriff (PDF)

Association of respiratory failure with inhibition of NaV1.6 in the phrenic nerve

Channels (Austin, Tex.), 2022-12, Vol.16 (1), p.230-243

2022

Volltextzugriff (PDF)

fMRI study of olfaction in the olfactory bulb and high olfactory structures of rats: Insight into their roles in habituation

NeuroImage (Orlando, Fla.), 2016-02, Vol.127, p.445-455

2016

Volltextzugriff (PDF)

Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice

Bioorganic & medicinal chemistry letters, 2017-05, Vol.27 (10), p.2087-2093

2017

Volltextzugriff (PDF)

Functional imaging of olfaction by CBV fMRI in monkeys: Insight into the role of olfactory bulb in habituation

NeuroImage (Orlando, Fla.), 2015-02, Vol.106, p.364-372

2015

Volltextzugriff (PDF)

Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model

Bioorganic & medicinal chemistry letters, 2017-06, Vol.27 (12), p.2683-2688

2017

Volltextzugriff (PDF)

Na v 1.7 target modulation and efficacy can be measured in nonhuman primate assays

Science translational medicine, 2021-05, Vol.13 (594)

2021

Volltextzugriff (PDF)

fMRI study of the role of glutamate NMDA receptor in the olfactory adaptation in rats: Insights into cellular and molecular mechanisms of olfactory adaptation

NeuroImage (Orlando, Fla.), 2017-04, Vol.149, p.348-360

2017

Volltextzugriff (PDF)

Discovery of Arylsulfonamide Nav1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity Profile

ACS medicinal chemistry letters, 2021-06, Vol.12 (6), p.1038-1049

2021

Volltextzugriff (PDF)

Discovery of Arylsulfonamide Na v 1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity Profile

ACS medicinal chemistry letters, 2021-06, Vol.12 (6), p.1038-1049

2021

Volltextzugriff (PDF)

Benzoxazolinone aryl sulfonamides as potent, selective Na v 1.7 inhibitors with in vivo efficacy in a preclinical pain model

Bioorganic & medicinal chemistry letters, 2017-06, Vol.27 (12), p.2683-2688

2017

Volltextzugriff (PDF)

Pharmacological validation of a novel nonhuman primate measure of thermal responsivity with utility for predicting analgesic effects

Journal of pain research, 2018-01, Vol.11, p.735-741

2018

Volltextzugriff (PDF)

Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na v 1.7 inhibitors with pain efficacy in mice

Bioorganic & medicinal chemistry letters, 2017-05, Vol.27 (10), p.2087-2093

2017

Volltextzugriff (PDF)

Design, synthesis, and structure–activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonists

Bioorganic & medicinal chemistry letters, 2010-12, Vol.20 (24), p.7327-7330

2010

Volltextzugriff (PDF)

Design, synthesis, and structure–activity relationship study of conformationally constrained analogs of indole-3-carboxamides as novel CB1 cannabinoid receptor agonists

Bioorganic & medicinal chemistry letters, 2010-08, Vol.20 (16), p.4918-4921

2010

Volltextzugriff (PDF)

Structure–activity relationships and CoMFA of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic properties

Bioorganic & medicinal chemistry, 2008-03, Vol.16 (6), p.2829-2851

2008

Volltextzugriff (PDF)

Peripheral morphine administration blocks the development of hyperalgesia and allodynia after bone damage in the rat

Anesthesiology (Philadelphia), 1998-07, Vol.89 (1), p.190-201

1998

Volltextzugriff (PDF)

Enhanced withdrawal responses to mechanical and thermal stimuli after bone injury

Pain (Amsterdam), 1997-12, Vol.73 (3), p.325-337

1997

Volltextzugriff (PDF)

The hypnotic, electroencephalographic, and antinociceptive properties of nonpeptide ORL1 receptor agonists after intravenous injection in rodents

Anesthesia and analgesia, 2007, Vol.104 (1), p.174-179

2007

Volltextzugriff (PDF)

Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative properties

Bioorganic & medicinal chemistry, 2007-02, Vol.15 (4), p.1828-1847

2007

Volltextzugriff (PDF)

Design, synthesis, and structure–activity relationships of indole-3-carboxamides as novel water soluble cannabinoid CB1 receptor agonists

MedChemComm, 2010-07, Vol.1 (1), p.54

2010

Volltextzugriff (PDF)

Do nociceptive signals from the pancreas travel in the dorsal column?

Pain (Amsterdam), 2001, Vol.89 (2), p.207-220

2001

Volltextzugriff (PDF)

Rapid access towards follow-up NOP receptor agonists using a knowledge based approach

Bioorganic & medicinal chemistry letters, 2009-11, Vol.19 (22), p.6441-6446

2009

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(58)

Sprache

Englisch
(58)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

fMRI study of olfactory processing in mice under three anesthesia protocols: Insight into the effect of ketamine on olfactory processing

fMRI study of the role of glutamate NMDA receptor in the olfactory processing in monkeys

Translational Pharmacokinetic-Pharmacodynamic Modeling of NaV1.7 Inhibitor MK-2075 to Inform Human Efficacious Dose

Association of respiratory failure with inhibition of NaV1.6 in the phrenic nerve

fMRI study of olfaction in the olfactory bulb and high olfactory structures of rats: Insight into their roles in habituation

Discovery of selective, orally bioavailable, N-linked arylsulfonamide Nav1.7 inhibitors with pain efficacy in mice

Functional imaging of olfaction by CBV fMRI in monkeys: Insight into the role of olfactory bulb in habituation

Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model

Na v 1.7 target modulation and efficacy can be measured in nonhuman primate assays

fMRI study of the role of glutamate NMDA receptor in the olfactory adaptation in rats: Insights into cellular and molecular mechanisms of olfactory adaptation

Discovery of Arylsulfonamide Nav1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity Profile

Discovery of Arylsulfonamide Na v 1.7 Inhibitors: IVIVC, MPO Methods, and Optimization of Selectivity Profile

Benzoxazolinone aryl sulfonamides as potent, selective Na v 1.7 inhibitors with in vivo efficacy in a preclinical pain model

Pharmacological validation of a novel nonhuman primate measure of thermal responsivity with utility for predicting analgesic effects

Discovery of selective, orally bioavailable, N-linked arylsulfonamide Na v 1.7 inhibitors with pain efficacy in mice

Design, synthesis, and structure–activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonists

Design, synthesis, and structure–activity relationship study of conformationally constrained analogs of indole-3-carboxamides as novel CB1 cannabinoid receptor agonists

Structure–activity relationships and CoMFA of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic properties

Peripheral morphine administration blocks the development of hyperalgesia and allodynia after bone damage in the rat

Enhanced withdrawal responses to mechanical and thermal stimuli after bone injury

The hypnotic, electroencephalographic, and antinociceptive properties of nonpeptide ORL1 receptor agonists after intravenous injection in rodents

Synthesis and evaluation of N-3 substituted phenoxypropyl piperidine benzimidazol-2-one analogues as NOP receptor agonists with analgesic and sedative properties

Design, synthesis, and structure–activity relationships of indole-3-carboxamides as novel water soluble cannabinoid CB1 receptor agonists

Do nociceptive signals from the pancreas travel in the dorsal column?

Rapid access towards follow-up NOP receptor agonists using a knowledge based approach

Suchergebnisse filtern